DexCom

DexCom

Yahoo Finance • yesterday

Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus

Wall Street regained some momentum on Friday, after the AI trade came under pressure on Thursday. The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-news%7Csection%3Amarket-news%7Csection_asset%3Aful... Full story

Yahoo Finance • 5 days ago

Citi reiterates these 2 medtech stocks as its top picks in the sector

Investing.com-- Citi reiterated its top picks in the medtech sector, highlighting Abbott Laboratories and Dexcom as standout opportunities while pointing to diverging fortunes across the industry. Before you buy NVIDIA: our AI model's sto... Full story

Yahoo Finance • 6 days ago

Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading

Dexcom U's season five roster features 27 athletes with Type 1 diabetes across 13 sports, marking the program's largest roster to date.Each athlete relies on Dexcom continuous glucose monitors like Dexcom G7 or Dexcom G7 15 Day to manage t... Full story

Yahoo Finance • 18 days ago

2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds

2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth i... Full story

Yahoo Finance • 19 days ago

DexCom (DXCM) Promotes Former CFO Jereme Sylvain To Chief Operating Officer

DexCom (NasdaqGS:DXCM) has promoted former Chief Financial Officer Jereme Sylvain to EVP and Chief Operating Officer. Healthcare executive Glenn S. Boehnlein has joined DexCom's board of directors, adding external industry experience to go... Full story

Yahoo Finance • 22 days ago

2 Nasdaq 100 Stocks for Long-Term Investors and 1 We Turn Down

2 Nasdaq 100 Stocks for Long-Term Investors and 1 We Turn Down The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenges like profitability conc... Full story

Yahoo Finance • 22 days ago

Global Wearable Biosensors Market Trends, Strategies and Forecast to 2036 Featuring Abbott Labs, Dexcom, Medtronic, Roche, Apple, Samsung Electronics Co., Garmin and Other Key Players

Company Logo Dublin, Sept. 21, 2026 (GLOBE NEWSWIRE) -- "Wearable Biosensors Market - Global Forecast to 2036" has been added to ResearchAndMarkets.com's offering. According to the research report, the global wearable biosensors market... Full story

Yahoo Finance • 22 days ago

Notable healthcare headlines for the week: Novo Nordisk, GE HealthCare, and Eli Lilly in focus

Wall Street's major market averages finished mixed as Treasury yields rebounded, rekindling concerns about a deteriorating macroeconomic backdrop. The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-n... Full story

Yahoo Finance • 25 days ago

2 Unpopular Stocks That Should Get More Attention and 1 We Question

2 Unpopular Stocks That Should Get More Attention and 1 We Question Wall Street's bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate... Full story

Yahoo Finance • 27 days ago

Stock futures rise as Fed rate decision takes center stage

[Wall Street street sign in Manhattan financial district] Alexey_Fedoren Stock index futures were higher on Wednesday as investors focused on the Federal Reserve's interest rate decision. Dow futures (INDU [https://seekingalpha.com/symbo... Full story

Yahoo Finance • last month

Dexcom Appoints Glenn Boehnlein to Board of Directors

SAN DIEGO, September 10, 2026--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Glenn Boehnlein to its Board of Directors, effective September 10, 2026. Mr. Boehnlein... Full story

Yahoo Finance • last month

3 Quality Compounders with Impressive Fundamentals

3 Quality Compounders with Impressive Fundamentals A quality compounder is a business that not only sports durable competitive advantages but also builds on its success by consistently reinvesting its profits at high returns. Companies s... Full story

Yahoo Finance • last month

Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services

Reviewing prior stock picks is how investors turn experience into valuable feedback. A recommendation is only a thesis until the market tests it. Watch Doug discuss recent stock picks, provide input on the current market environment—and... Full story

Yahoo Finance • last month

3 Reasons DXCM Has Explosive Upside Potential

3 Reasons DXCM Has Explosive Upside Potential Over the past six months, DexCom has been a great trade, beating the S&P 500 by 11.5%. Its stock price has climbed to $91.17, representing a healthy 23.6% increase. This was partly due to its... Full story

Yahoo Finance • 2 months ago

FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories' Libre Duo 10 Day Continuous Dual Glucose Ketone Moni... Full story

Yahoo Finance • 2 months ago

Abbott vs. DexCom: Which CGM Stock Is the Better Buy Now?

Abbott Laboratories ABT and DexCom DXCM are two of the most prominent players in the continuous glucose monitoring (CGM) space. Abbott has continued to enhance its continuous monitoring portfolio through product upgrades, expanded indicati... Full story

Yahoo Finance • 2 months ago

Oura is reportedly eyeing a September IPO that could value it at more than $16B

Oura, the smart ring maker, with offices in San Francisco and Finland, is reportedly planning to raise up $3 billion as soon as next month in a U.S. IPO that values the more than 900-person company at north of $16 billion, according to Blo... Full story

Yahoo Finance • 2 months ago

1 Healthcare Stock to Target This Week and 2 Facing Headwinds

1 Healthcare Stock to Target This Week and 2 Facing Headwinds Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from ele... Full story

Yahoo Finance • 2 months ago

1 Surging Stock Worth Your Attention and 2 We Question

1 Surging Stock Worth Your Attention and 2 We Question Exciting developments are taking place for the stocks in this article. They've all surged ahead of the broader market over the last month as catalysts such as new products and positiv... Full story

Yahoo Finance • 2 months ago

US Stock Market Today: S&P 500 Futures Rise On Stronger Sentiment And High-Rate Test

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. The Morning Bull - US Market Morning Update Monday, Aug, 3 2026 US stock futures are pointing h... Full story